methylprednisolone and bufexamac

methylprednisolone has been researched along with bufexamac in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL	1
Dequeker, J; Mardjuadi, A	1
Mielants, H; Proot, F; Raeman, F; Veys, EM	1
Nixon, R; Shen, S; Wong, GN	1

Trials

2 trial(s) available for methylprednisolone and bufexamac

Article	Year
Double-blind trial comparing bufexamac infiltrations with triamcinolone acetonide infiltrations in patients with periarthritis of the shoulder. Current medical research and opinion, 1978, Volume: 5, Issue:5 Topics: Adult; Aged; Bufexamac; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydroxamic Acids; Injections; Lidocaine; Male; Methylprednisolone; Middle Aged; Periarthritis; Shoulder Joint; Triamcinolone Acetonide	1978
Intra-articular treatment of inflammatory arthritis: double-blind trial comparing bufexamac with methylprednisolone acetate. Clinical rheumatology, 1987, Volume: 6, Issue:1 Topics: Anti-Inflammatory Agents; Arthritis; Bufexamac; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydroxamic Acids; Injections, Intra-Articular; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged	1987

Article

Year

Double-blind trial comparing bufexamac infiltrations with triamcinolone acetonide infiltrations in patients with periarthritis of the shoulder.

Current medical research and opinion, 1978, Volume: 5, Issue:5

Topics: Adult; Aged; Bufexamac; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydroxamic Acids; Injections; Lidocaine; Male; Methylprednisolone; Middle Aged; Periarthritis; Shoulder Joint; Triamcinolone Acetonide

1978

Intra-articular treatment of inflammatory arthritis: double-blind trial comparing bufexamac with methylprednisolone acetate.

Clinical rheumatology, 1987, Volume: 6, Issue:1

Topics: Anti-Inflammatory Agents; Arthritis; Bufexamac; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hydroxamic Acids; Injections, Intra-Articular; Male; Methylprednisolone; Methylprednisolone Acetate; Middle Aged

1987

Other Studies

2 other study(ies) available for methylprednisolone and bufexamac

Article	Year
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics. PloS one, 2016, Volume: 11, Issue:10 Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat	2016
Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization. Contact dermatitis, 2019, Volume: 80, Issue:6 Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Bufexamac; Chemotherapy, Adjuvant; Dermatitis, Allergic Contact; Edema; Erythema; Facial Dermatoses; Histamine Antagonists; Hospitalization; Humans; Methylprednisolone; Ointments	2019

Article

Year

Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.

PloS one, 2016, Volume: 11, Issue:10

Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016

Severe allergic contact dermatitis caused by topical bufexamac requiring hospitalization.

Contact dermatitis, 2019, Volume: 80, Issue:6

Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Bufexamac; Chemotherapy, Adjuvant; Dermatitis, Allergic Contact; Edema; Erythema; Facial Dermatoses; Histamine Antagonists; Hospitalization; Humans; Methylprednisolone; Ointments

2019